Allergic contact dermatitis from dibucaine hydrochloride, chlorpheniramine maleate, and naphazoline hydrochloride in an over-the-counter topical antiseptic.
Yamadori
Yoshika
Y
Department of Dermatology, Kinki University School of Medicine, Ohno-Higashi, Osaka-Sayama, Osaka, Japan.
Oiso
Naoki
N
Hirao
Ayaka
A
Kawara
Shigeru
S
Kawada
Akira
A
D000316:Adrenergic alpha-Agonists / Q000009:adverse effects*; D000369:Aged, 80 and over; D000779:Anesthetics, Local / Q000009:adverse effects*; D018926:Anti-Allergic Agents / Q000009:adverse effects*; D000891:Anti-Infective Agents, Local / Q000009:adverse effects*; D002744:Chlorpheniramine / Q000009:adverse effects*; D017449:Dermatitis, Allergic Contact / Q000175:diagnosis / Q000209:etiology*; D003992:Dibucaine / Q000009:adverse effects*; D003875:Drug Eruptions / Q000175:diagnosis / Q000209:etiology*; D006801:Humans; D008297:Male; D009278:Naphazoline / Q000009:adverse effects*; D004366:Nonprescription Drugs / Q000009:adverse effects; D010328:Patch Tests
D000316:Adrenergic alpha-Agonists; D000779:Anesthetics, Local; D018926:Anti-Allergic Agents; D000891:Anti-Infective Agents, Local; D004366:Nonprescription Drugs; D002744:Chlorpheniramine; D009278:Naphazoline; D003992:Dibucaine